Bullish case
$165 to $180
More likely if crush margins stay healthy, Viterra synergies scale, free cash flow turns positive, leverage comes down, and BG reclaims its moving averages.
Bunge Global SA research snapshot
BG AI stock analysis reads Bunge Global as a globally diversified agribusiness that delivered a strong second quarter 2026, raised its full year adjusted EPS outlook to $9.25 to $9.75, and completed the $2 billion Viterra-related share repurchase program. At the August 2, 2026 data cutoff, the latest public close was $106.23 on July 31, 2026, with a verified market capitalization near $20.41 billion and 192.12 million shares outstanding. The stock pulled back from its June 2026 high near $134.87 and closed below its 20 day, 50 day, and 200 day moving averages, which keeps the near term setup cautious even though the reported earnings trajectory improved. This page is informational research, not investment advice.
Current price
$106.23
Market cap
$20.41 billion
AI score
68 / 100
Rating
Diversified agribusiness, raised outlook, leverage and trend risk
Trend status
Short-term downtrend below all major moving averages, RSI near oversold
Data cutoff (updated monthly)
August 4, 2026
Informational use only. This page is not investment advice.
| Dimension | Conclusion | Confidence |
|---|---|---|
| Business quality | Bunge connects farmers, processors, food companies, feed customers, and fuel markets across soybean, softseed, tropical oil, and grain value chains. | Medium-high |
| Moat | Scale, origination networks, processing assets, logistics, customer relationships, and risk management create advantages, but commodity economics limit pricing power. | Medium |
| Management | CEO Greg Heckman and CFO John Neppl delivered a strong Q2 2026, raised guidance, and completed the $2 billion Viterra buyback; the test is synergy capture and balance sheet control. | Medium-high |
| Financial trend | Q2 2026 GAAP diluted EPS was $3.47, adjusted EPS $2.00, and adjusted segment EBIT $796 million, and FY2026 adjusted EPS guidance was raised to $9.25 to $9.75. | High |
| Valuation | At $106.23, BG trades near 20.7x trailing EPS but about 11x forward adjusted EPS using the $9.50 guidance midpoint, with book value near 1.31x and sales near 0.22x. | Medium |
| Technical trend | BG closed below its 5 day, 20 day, 50 day, 100 day, and 200 day moving averages, with 14 day RSI near 34.62, a bearish short-term structure near oversold. | Medium |
| Risk level | Main risks are crush margin normalization, weather and El Nino, trade and biofuel policy, Black Sea conflict, net debt near $16 billion, and negative trailing twelve month free cash flow. | Medium-high |
| AI confidence | Data confidence is high because reported information is rich and cross-checked. Return confidence is lower because agribusiness earnings can swing quickly with spreads, weather, and policy. | High data confidence |
| Investment certainty | The earnings outlook improved, but the stock still needs proof that synergies and free cash flow outweigh leverage and a broken technical trend. | Medium-low |
BG AI stock forecast
The BG AI stock forecast should be read as scenario math, not a guaranteed price target. Using the FY2026 adjusted EPS guidance midpoint of $9.50, a July 31, 2026 price reference near $106.23, and a three-year framework, the tested range spans about $65 in a bear case, $124 in a base case, and $173 in a bullish case before dividends. These are scenario outputs, not promises.
$165 to $180
More likely if crush margins stay healthy, Viterra synergies scale, free cash flow turns positive, leverage comes down, and BG reclaims its moving averages.
$118 to $130
More likely if adjusted EPS compounds at a low double digit rate, the market holds a mid-to-high single digit forward multiple, and integration executes without major margin or weather shocks.
$60 to $70
More likely if crush margins weaken, weather or trade policy disrupts volumes, working capital absorbs cash, leverage stays high, or the market cuts the multiple.
BG AI technical analysis
BG AI technical analysis is bearish as of the August 2, 2026 data cutoff. The July 31, 2026 close was $106.23, down from the June 3, 2026 52-week high of $134.87. Barchart reported the stock below its 5 day ($110.79), 20 day ($115.56), 50 day ($117.83), 100 day ($121.29), and 200 day ($111.91) moving averages, with 14 day RSI near 34.62 and 14 day historic volatility near 42.46%.
| Level | Value | Why it matters |
|---|---|---|
| Current price | $106.23 | StockAnalysis reported the July 31, 2026 close at $106.23, up 1.10% on the day. |
| Immediate support | $104.41 to $105 | The July 31 low of $104.41 and the surrounding lows mark the first support zone. |
| Secondary support | $100 area | The round $100 level is the next reference after the $104.41 low, with the 52-week low of $76.01 well below. |
| Near resistance | $110.79 to $111.91 | The 5 day moving average and the 200 day moving average cluster here, the first repair zone. |
| Higher resistance | $115.56 to $117.83 | The 20 day and 50 day moving averages sit in this zone and would need to be reclaimed for trend repair. |
| Far resistance | $134.87 | Barchart and StockAnalysis report this as the June 3, 2026 52-week high. |
| Moving averages | 5-day $110.79, 20-day $115.56, 50-day $117.83, 100-day $121.29, 200-day $111.91 | The price sits below every major average, a bearish short-term alignment with no MA support underneath. |
| Momentum | RSI 34.62 (14-day), 28.98 (9-day) | RSI is near oversold, which can set up a bounce, but it also means momentum has not turned. |
| Volume | 1.60M on July 31 vs 1.33M 20-day average | The July 31 advance came on slightly above average volume, a mild confirmation, not a breakout. |
| Volatility | 14-day historic volatility near 42.46% | Barchart reported elevated volatility, so position sizing should account for larger daily swings. |
| Invalidation (downside) | Close below $104.41 | A close below the July 31 low would confirm weakness toward the $100 area and lower. |
| Invalidation (repair) | Close above $111.91 | A close above the 200 day moving average would be the first signal that the pullback is repairing. |
BG AI trading strategy
The BG AI trading strategy below is a rules-based research framework, not personal advice. It combines the improved Q2 2026 earnings outlook, crush margin and integration evidence, technical confirmation, and predefined invalidation levels.
Wait for BG to reclaim the 200 day moving average near $111.91, hold above it, and rebuild volume while free cash flow and synergy evidence improve before treating the trend as repaired.
A close back below the 200 day moving average or a failed reclaim with weak volume invalidates the repair setup.
If BG holds the $104.41 to $105 support with RSI near oversold and no deterioration in crush margins, guidance, or integration updates, compare the setup against earnings evidence.
Avoid averaging down below $104.41, and especially below $100, unless free cash flow and leverage improve and the technical structure stabilizes.
Track soybean and softseed processing EBIT, grain merchandising volumes, Viterra synergy capture, net debt, leverage ratio, free cash flow, working capital, dividends, buybacks, and biofuel policy.
Do not treat low price-to-sales or price-to-book ratios as risk controls. Position sizing should account for commodity spreads, weather, geopolitics, and working capital swings.
Investment research summary
Bunge earns money by moving, processing, refining, and merchandising agricultural commodities that food, feed, and fuel customers need every day. Customers pay because reliability, origination access, logistics, and risk management matter more than spot-price matching alone.
The moat comes from asset scale, global origination and logistics, processing capacity, customer relationships, trade finance capability, and commodity risk systems. The moat is real but not absolute because crop processing is cyclical and commodity-like.
The thesis fails if crush margins normalize, weather or trade policy disrupts volumes, Viterra synergies absorb capital without delivery, debt stays high, or working capital consumes cash faster than earnings build.
Greg Heckman and John Neppl delivered a strong Q2 2026, raised FY2026 adjusted EPS guidance to $9.25 to $9.75, and completed the $2 billion Viterra-related buyback. The central management test is whether the enlarged company keeps capturing synergies while lowering leverage and restoring free cash flow.
Bunge sits inside long-term food security, protein demand, vegetable oils, renewable fuels, and global grain trade. These are durable needs, but annual profits still depend on crop cycles, spreads, weather, and policy.
At about 20.7x trailing EPS but near 11x forward adjusted EPS, with book value near 1.31x and sales near 0.22x, BG is cheaper on forward earnings. Margin of safety depends on guidance delivery, synergy capture, lower debt, and a technical repair.
Source-backed data
Every metric below includes a source and last verification date.
| Metric | Value | Source | Last verified |
|---|---|---|---|
| BG closing price | $106.23 on July 31, 2026 | StockAnalysis quote snapshot | July 31, 2026 |
| Shares outstanding | 192.12 million | StockAnalysis statistics | August 1, 2026 |
| Market cap | $20.41 billion, verified as $106.23 x 192.12 million shares | financial_rigor.py market cap verification | August 2, 2026 |
| Q2 2026 GAAP diluted EPS | $3.47 vs $2.61 in the prior year | Bunge Q2 2026 earnings release | July 29, 2026 |
| Q2 2026 adjusted EPS | $2.00 vs $1.31 in the prior year | Bunge Q2 2026 earnings release | July 29, 2026 |
| Q2 2026 net income attributable to Bunge | $678 million vs $354 million in the prior year | Bunge Q2 2026 earnings release | July 29, 2026 |
| FY2026 adjusted EPS guidance | $9.25 to $9.75, raised from $9.00 to $9.50 | Bunge Q2 2026 earnings release | July 29, 2026 |
| Q2 2026 adjusted segment EBIT | $796 million vs $373 million in the prior year | Bunge Q2 2026 earnings release | July 29, 2026 |
| Viterra-related buyback | About $250 million repurchased in Q2, completing the $2 billion program | Bunge Q2 2026 earnings release | July 29, 2026 |
| Cash and debt at June 30, 2026 | $638M cash and short-term investments, $16.8B total debt, net debt near $16.2B | StockAnalysis balance sheet | July 29, 2026 |
| TTM cash flow | $1.08 billion operating cash flow less $1.79 billion capex, or about negative $711 million free cash flow | StockAnalysis statistics | August 1, 2026 |
| TTM income statement | $91.82 billion revenue, $1.01 billion net income, $5.13 EPS | StockAnalysis overview and statistics | August 1, 2026 |
| Analyst consensus | Buy with an average target of $141.22 across 9 analysts, low $116 and high $150 | StockAnalysis forecast | July 31, 2026 |
| Valuation check | PE 20.66, forward PE 9.90, PB 1.28, PS 0.22, dividend yield 2.71% | StockAnalysis statistics and financial_rigor.py verification | August 1, 2026 |
| Technical indicators | RSI 34.62, 5-day MA $110.79, 20-day $115.56, 50-day $117.83, 100-day $121.29, 200-day $111.91 | Barchart technical analysis | July 31, 2026 |
| Short interest | 6.29 million shares, 3.27% of shares outstanding, 3.69 days to cover | StockAnalysis statistics | August 1, 2026 |
This BG AI stock analysis is an informational research tool only and is not investment advice, a recommendation, or a solicitation to buy or sell securities. Forecast scenarios are based on available public data as of August 2, 2026 and can be wrong if earnings, commodity cycles, weather, interest rates, Viterra integration, trade policy, or market sentiment change.
Design trading strategies visually with 10+ indicators. Set entry/exit conditions and risk management, then generate Pine Script code with no coding required.
Filter and discover stocks based on market cap, dividend yield, P/E ratio, sector, and more. Screen thousands of stocks with real-time data.
Smart AI-driven stock selection with fundamental screening, analyst estimates, and key metrics. Filter by P/E, market cap, dividends, and more.